Scientists have created a compact and efficient gene-editing tool, called engineered AsCas12f, smaller than the common Cas9 enzyme. It was tested successfully in mice, demonstrating promise for treating genetic disorders like hemophilia. The key advantage is that it can be packed more efficiently into delivery systems, potentially advancing gene therapy for humans. However, further research is needed to establish safe and effective delivery methods.
Related Posts
New Macrocycles Bind and Transport Anions with High Efficiency
Scientists have crafted novel macrocycles, composed of aromatic rings and amide bonds, that adeptly capture and transport anions. Their rigid structure compels hydrogen bond donors inward, forming a highly electropositive cavity ideal for anion binding. Moreover, these macrocycles can integrate into bio-membranes, facilitating anion transport across cell membranes. This breakthrough holds promise for treating conditions […]
New Method Could Bring High-Performance Semiconductor Materials to Market at Lower Cost
Researchers have developed a new method for synthesizing metal halide perovskite high-entropy semiconductor (HES) single crystals at room temperature. This method is much simpler and more efficient than traditional methods, which require high temperatures and complex processing techniques. HES single crystals are excellent candidates for a range of functional materials, including solar cells, LEDs, and […]
Blood Unveils Disease Secrets: Tiny Power Plants Hold the Key
Deep within your cells lies a hidden world of miniature power plants, tirelessly generating energy to fuel your body’s every function. These powerhouses, known as mitochondria, play a critical role in maintaining health, but their malfunctions can pave the way for disease. Until recently, investigating these “mitochondrial glitches” required invasive tissue biopsies. But a groundbreaking […]